These Analysts Cut Their Forecasts On SI-BONE Following Q2 Results
Portfolio Pulse from Avi Kapoor
SI-BONE, Inc. (NASDAQ:SIBN) reported a Q2 loss of 22 cents per share, beating the analyst consensus estimate of 28 cents per share. Quarterly sales were $39.969 million, surpassing the estimate of $38.319 million. Despite strong operating results and increased revenue guidance for 2024, shares fell 4.8%. Analysts from Needham and Truist Securities lowered their price targets.
August 06, 2024 | 12:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
SI-BONE reported better-than-expected Q2 results but shares fell 4.8%. Analysts from Needham and Truist Securities lowered their price targets despite strong operating results and increased revenue guidance for 2024.
Despite beating earnings and revenue estimates, the stock fell 4.8% due to lowered price targets from analysts. This indicates a negative short-term sentiment among investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100